US biopharma Biohaven has been told by the US Food and Drug Administration (FDA) that the agency is extending the PDUFA date ...

Irish contract research organization ICON (Nasdaq: ICON) has retained its position as the most active CRO worldwide in the ...

US clinical-stage biotech Therini Bio yesterday revealed that it raised $39 million in a Series A extension financing, which ...

Pathos AI, a US biotech specializing in artificial intelligence for cancer drug development, has raised $365 million in a ...

Neurocrine Biosciences, the American biotech, has unveiled new data showing its drug Crenessity (crinecerfont) may help ...

New York-based Pathos AI, a biotech company applying artificial intelligence (AI) to drug development, has announced a $365 ...

The US Food and Drug Administration’s (FDA biosimilar approvals reached a record 19 in 2024, with projections indicating that ...

A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

The US Food and Drug Administration (FDA) has approved Incyte’s (Nasdaq: INCY) Zynyz (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination ...

The Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative clinical effectiveness and value of sonpiretigene isteparvovec for the treatment of ...

New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...